Kiyatec

Develops 3D phenotypic cell-based assays and diagnostic solutions for prediction of patients’ response to cancer drug treatment

placePendleton, Oregon, United States calendar_todayFounded 2005 groups28 employees language kiyatec.com

Registered entities

Innovation

6 patent families (4 granted) — focus: Physics & computing, Chemistry & metallurgy; filing pace slowing. Cited 235 times.

YearFilings
20123
20132
20141
20152
20161
20173
20181
20192
20201
20213
20223
20231

Social engagement

Social engagement: 3K social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

15 investors on record; lead investors include Esperante, SCRA, VentureSouth, Bruker.

Investor typeCountShare
Venture capital747%
Private equity17%
Accelerator & incubator17%
Other / undisclosed640%

Recent activity

2 Mar 2026
Product launch
3D Predict Glioma shipping kits
Coming soon